Benign prostatic hyperplasia and new treatment options – a critical appraisal of the UroLift system

Código QR

Benign prostatic hyperplasia and new treatment options – a critical appraisal of the UroLift system

Thomas Anthony McNicholas1–3 1Section of Urology, Royal Society of Medicine, London, UK; 2Urology Department, Lister Hospital, East and North Herts NHS Trust, Stevenage, UK; 3Faculty of Health and Human Sciences, University of Hertfordshire, Hatfield, Herts, UK Abstract: The prostatic ure...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	McNicholas TA
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	Urolift prostatic urethral lift Lower urinary tract symptoms (LUTS) Male Benign prostatic hyperplasia Minimally invasive surgical procedure Prostate Therapy Urethra Medical technology R855-855.5
Acceso en línea:	https://doaj.org/article/2cbc80d3f2bd4235b76d715f462fab39
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Putting Patients Ahead by Leaving Nothing Behind: An Emerging Treatment Paradigm in Minimally Invasive Surgical Therapy for Benign Prostatic Hyperplasia
por: McVary KT, et al.
Publicado: (2021)

Correlation of prostate volume with 'International Prostate Symptom Score' and 'Benign Prostatic Hyperplasia-Impact Index' in benign prostatic hyperplasia
por: D Gnyawali, et al.
Publicado: (2016)

Perspective on the Rezūm® System: a minimally invasive treatment strategy for benign prostatic hyperplasia using convective radiofrequency water vapor thermal therapy
por: Woo HH, et al.
Publicado: (2017)

Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males
por: Lee WC, et al.
Publicado: (2013)

Sildenafil citrate in combination with tamsulosin versus tamsulosin monotherapy for management of male lower urinary tract symptoms due to benign prostatic hyperplasia: A randomised, double-blind, placebo-controlled trial
por: Amr Fawzi, et al.
Publicado: (2017)

Efficacy and safety of prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: a systematic review and meta-analysis
por: Wang XY, et al.
Publicado: (2016)

The safety and efficacy of aspirin intake in photoselective vaporization laser treatment of benign prostate hyperplasia
por: Shao IH, et al.
Publicado: (2013)

High Concentration of Reticular Fibers in Periurethral Region of the Prostatic Urethra from Patients with Benign Prostatic Hyperplasia as Revealed by Stereology
por: Manaia,Jorge H. M, et al.
Publicado: (2012)

Relationship between Dietary Patterns with Benign Prostatic Hyperplasia and Erectile Dysfunction: A Collaborative Review
por: Giorgio Ivan Russo, et al.
Publicado: (2021)

The Impact of Illness Perceptions on Depressive Symptoms Among Benign Prostatic Hyperplasia Patients with Lower Urinary Tract Symptom
por: Yang L, et al.
Publicado: (2021)

Multicenter, prospective, comparative cohort study evaluating the efficacy and safety of alfuzosin 10 mg with regard to blood pressure in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia with or without antihypertensive med
por: Zhang LT, et al.
Publicado: (2015)

Incidence and Risk Factors of Post-Operative Depression in Patients Undergoing Transurethral Resection of Prostate for Benign Prostatic Hyperplasia
por: Zhu D, et al.
Publicado: (2021)

High degree of prostate related LUTS in a prospective cross-sectional community study in Ghana (Mamprobi)
por: George A. Asare, et al.
Publicado: (2021)

Comparison of the Efficacy and Safety of Minimally Invasive Simple Prostatectomy and Endoscopic Enucleation of Prostate for Large Benign Prostatic Hyperplasia
por: Jinze Li, et al.
Publicado: (2021)

Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily
por: Claus G Roehrborn, et al.
Publicado: (2008)

Comparison between selected hormone and protein levels in serum and prostate tissue homogenates in men with benign prostatic hyperplasia and metabolic disorders
por: Grzesiak K, et al.
Publicado: (2018)

Personalized therapeutics of α1-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
por: Zhu LL, et al.
Publicado: (2015)

Mini-invasive reconstruction technique of the bulbomembranous urethra
por: V. A. Vorobyev, et al.
Publicado: (2018)

Urinary Tract Stones Risk Factors in Patients with Benign Prostatic Hyperplasia in West Java, Indonesia
por: Iman Surendroputro Tjahjodjati, et al.
Publicado: (2021)

Correlation of Detrusor Wall Thickness with International Prostate Symptom Score: A Cross-sectional Study of Nigerian Men with Prostate-Related Diseases
por: OBASI AUGUSTINE ULEBE, et al.
Publicado: (2021)

Evaluation of ‘Visual prostate symptom score’ in men with benign enlargement of prostate in a tertiary care center in midwestern Nepal
por: Dipesh Kumar Gupta
Publicado: (2017)

Efficacy and safety of tamsulosin hydrochloride 0.2 mg and combination of tamsulosin hydrochloride 0.2 mg plus solifenacin succinate 5 mg after transurethral resection of the prostate: a prospective, randomized controlled trial
por: Shin YS, et al.
Publicado: (2016)

Circulating Tumor Cells as a Novel Prostate Cancer Diagnostic Tool
por: Fatemeh Khatami, et al.
Publicado: (2020)

Prostate Artery Embolization—Review of Indications, Patient Selection, Techniques and Results
por: Sailendra G. Naidu, et al.
Publicado: (2021)

A systematic review of herbal medicine in the clinical treatment of benign prostatic hyperplasia
por: Kristian Leisegang, et al.
Publicado: (2022)

Identificación de factor de crecimiento vascular endotelial en células glandulares de tejido prostético maligno y benigno: Relación con la recidiva tumoral al año de la prostatectomía
por: Acuña,Pedro, et al.
Publicado: (2013)

Osteopontin Deficiency Ameliorates Prostatic Fibrosis and Inflammation
por: Petra Popovics, et al.
Publicado: (2021)

Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats
por: Al-Trad B, et al.
Publicado: (2019)

Research on Applications of Transurethral Plasmakinetic Enucleation of the Prostate in Elderly Patients Aged ≥80 Years
por: Wen Su, et al.
Publicado: (2021)

Comparative Evaluation of Post-TURP Complications in Patients with BPH Presenting with and Without Acute Urinary Retention
por: Veda Murthy Reddy Pogula, et al.
Publicado: (2021)

Influence of р-thyrozol on the morphology and antioxidant-prooxidant balance in prostate of rats at sulpiride-induced benign prostatic hyperplasia
por: T. G. Borovskaya, et al.
Publicado: (2014)

Clinical Efficacy of Transurethral Resection of the Prostate Combined with Oral Anticholinergics or Botulinum Toxin – A Injection to Treat Benign Prostatic Hyperplasia with Overactive Bladder: A Case–Control Study
por: Allameh F, et al.
Publicado: (2020)

An open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with treatment with 0.2 mg tamsulosin
por: Yang PS, et al.
Publicado: (2018)

Towards personalized prostate cancer screening
por: Filella Xavier
Publicado: (2020)

Is diabetes mellitus associated with clinical outcomes in aging males treated with transurethral resection of prostate for bladder outlet obstruction: implications from Taiwan Nationwide Population-Based Cohort Study
por: Lin YH, et al.
Publicado: (2017)

Two Novel Ceramide-Like Molecules and miR-5100 Levels as Biomarkers Improve Prediction of Prostate Cancer in Gray-Zone PSA
por: Maurizia Mello-Grand, et al.
Publicado: (2021)

ROLE OF COMBINED KETOCONAZOLE AND TAMSULOSIN IN SUCCESSFUL TRIAL OF VOIDING WITHOUT CATHETER (TWOC) IN PATIENTS WITH ACUTE URINARY RETENTION DUE TO BENIGN PROSTATIC OBSTRUCTION
por: Muhammad Asim, et al.
Publicado: (2020)

EFFECT OF DUTASTERIDE IN DECREASING SURGICAL BLOOD LOSS FOLLOWING UNIPOLAR TRANSURETHRAL RESECTION OF PROSTATEIN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA: A QUASI EXPERIMENTAL STUDY
por: Mujahid Ali Khoso, et al.
Publicado: (2019)

Use of the SF-36 quality of life scale to assess the effect of pelvic floor muscle exercise on aging males who received transurethral prostate surgery
por: Hou CP, et al.
Publicado: (2013)

Correlating complications of transurethral complications of prostate using the Charlson’s Comorbidity Index
por: Aditya Kumar, et al.
Publicado: (2016)